Clinical Trial Update: SAMe in Prevention of Oxaliplatin-associated Liver Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating S-adenosyl-L-methionine (SAMe) to prevent oxaliplatin-associated liver injury in patients with colorectal cancer and li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases
• Sinusoidal Obstruction Syndrome

Drugs mentioned

• SAMe (S-adenosyl-L-methionine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Colorectal Cancer, Liver Metastases | Phase 2 | Status: NOT_YET_RECRUITING